<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37620042</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Tailored psychological intervention for anxiety or depression in COPD (TANDEM): a randomised controlled trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2300432</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.00432-2023</ELocationID><Abstract><AbstractText Label="BACKGROUND">The TANDEM multicentre, pragmatic, randomised controlled trial evaluated whether a tailored psychological intervention based on a cognitive behavioural approach for people with COPD and symptoms of anxiety and/or depression improved anxiety or depression compared with usual care (control).</AbstractText><AbstractText Label="METHODS">People with COPD and moderate to very severe airways obstruction and Hospital Anxiety and Depression Scale subscale scores indicating mild to moderate anxiety (HADS-A) and/or depression (HADS-D) were randomised 1.25:1 (242 intervention and 181 control). Respiratory health professionals delivered the intervention face-to-face over 6-8&#x2005;weeks. Co-primary outcomes were HADS-A and HADS-D measured 6&#x2005;months post-randomisation. Secondary outcomes at 6 and 12&#x2005;months included: HADS-A and HADS-D (12&#x2005;months), Beck Depression Inventory II, Beck Anxiety Inventory, St George's Respiratory Questionnaire, social engagement, the EuroQol instrument five-level version (EQ-5D-5L), smoking status, completion of pulmonary rehabilitation, and health and social care resource use.</AbstractText><AbstractText Label="RESULTS">The intervention did not improve anxiety (HADS-A mean difference -0.60, 95% CI -1.40-0.21) or depression (HADS-D mean difference -0.66, 95% CI -1.39-0.07) at 6&#x2005;months. The intervention did not improve any secondary outcomes at either time-point, nor did it influence completion of pulmonary rehabilitation or healthcare resource use. Deaths in the intervention arm (13/242; 5%) exceeded those in the control arm (3/181; 2%), but none were associated with the intervention. Health economic analysis found the intervention highly unlikely to be cost-effective.</AbstractText><AbstractText Label="CONCLUSION">This trial has shown, beyond reasonable doubt, that this cognitive behavioural intervention delivered by trained and supervised respiratory health professionals does not improve psychological comorbidity in people with advanced COPD and depression or anxiety.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Stephanie J C</ForeName><Initials>SJC</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Queen Mary University of London, London, UK s.j.c.taylor@qmul.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohanpal</LastName><ForeName>Ratna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steed</LastName><ForeName>Liz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1902-3846</Identifier><AffiliationInfo><Affiliation>Chest Clinic, RVI Hospital, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yaziji</LastName><ForeName>Nahel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barradell</LastName><ForeName>Amy C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre - Respiratory, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Font-Gilabert</LastName><ForeName>Paulino</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Healey</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooper</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Moira J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mammoliti</LastName><ForeName>Kristie-Marie</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0003-3614-7453</Identifier><AffiliationInfo><Affiliation>WHO Collaborating Centre on Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Priebe</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajasekaran</LastName><ForeName>Arvind</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>C Michael</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Centre for Digital Transformation of Health, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowland</LastName><ForeName>Vickie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Population Health, School of Life Course and Population Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sally J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-9834-0366</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smuk</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Blizard Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Underwood</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospitals of Coventry and Warwickshire, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waseem</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Women's Health Division, University College Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Population Health, School of Life Course and Population Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wileman</LastName><ForeName>Vari</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Health Psychology, School of Mental Health and Psychological Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinnock</LastName><ForeName>Hilary</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5976-8386</Identifier><AffiliationInfo><Affiliation>Allergy and Respiratory Research Group, Usher Institute, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN59537391</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>13/146/02</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2023 Nov 2;62(5):2301538. doi: 10.1183/13993003.01538-2023</RefSource><PMID Version="1">37918881</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2024 Jan 4;63(1):2302149. doi: 10.1183/13993003.02149-2023</RefSource><PMID Version="1">38176703</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2024 Jan 4;63(1):2301857. doi: 10.1183/13993003.01857-2023</RefSource><PMID Version="1">38176705</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="Y">Depression</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083626" MajorTopicYN="N">Psychosocial Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of interest: L. Steed reports support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02), and also reports lecture honoraria from the IPCRG, outside the submitted work. K. Marshall reports support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02), and also reports lecture honoraria, outside the submitted work. S.J. Singh reports support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02); in addition, S.J. Singh also reports grants from the NIHR (NIHR 202020 and senior investigator grant), Wellcome Doctoral Training Programme, HTA Project Grant (NIHR 131015), NIHR DHSC/UKRI COVID-19 Rapid Response Initiative, NIHR Global Research Group (NIHR 17/63/20) and Actegy Limited, lecture honoraria from GSK, Ministry of Justice, CIPLA and Sherbourne Gibbs, advisory board participation with NICE (Expert Adviser Panel &#x2013; Long COVID) and the Wales Long COVID Advisory Board (expired), and leadership roles with the ATS (Pulmonary Rehabilitation Assembly Chair), RCP Pulmonary Rehabilitation Accreditation Scheme and NACAP Audit for Pulmonary Rehabilitation, outside the submitted work. M. Underwood is chief investigator or co-investigator on previous and current research grants from the UK NIHR, Arthritis Research UK and on grants funded by the Australian NHMRC and Norwegian MRC; he was an NIHR Senior Investigator until March 2021. He has received travel expenses for speaking at conferences from the professional organisations hosting the conferences. He is a director and shareholder of Clinvivo Ltd. He is part of an academic partnership with Serco Ltd, funded by the European Social Fund. He is a co-investigator studies that are, or have had, additional support from Stryker Ltd. Until March 2020 he received a fee as an NIHR journal editor and editors group member. V. Wileman reports support for the present manuscript from the NIHR Applied Research Collaboration (ARC) North Thames. P. White is a chief investigator or co-investigator on multiple previous and current research grants from the NIHR, and reports travel expenses for speaking at conferences from the professional organisations hosting the conferences. H. Pinnock reports support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02), and also reports lecture honoraria from Sandoz, Teva and Boehringer Ingelheim, outside the submitted work. S.J.C. Taylor, R. Sohanpal, S. Priebe, A. Healey, S. Waseem, M.J. Kelly and C.M. Roberts report support for the present manuscript from the NIHR Health Technology Assessment programme (project number 13/146/02). All other authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37620042</ArticleId><ArticleId IdType="pmc">PMC10620475</ArticleId><ArticleId IdType="doi">10.1183/13993003.00432-2023</ArticleId><ArticleId IdType="pii">13993003.00432-2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vanfleteren LEGW, Spruit MA, Wouters EFM, et al. . Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med 2016; 4: 911&#x2013;924. doi:10.1016/S2213-2600(16)00097-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00097-7</ArticleId><ArticleId IdType="pubmed">27264777</ArticleId></ArticleIdList></Reference><Reference><Citation>Tselebis A, Pachi A, Ilias I, et al. . Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat 2016; 12: 297&#x2013;328. doi:10.2147/NDT.S79354</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S79354</ArticleId><ArticleId IdType="pmc">PMC4755471</ArticleId><ArticleId IdType="pubmed">26929625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev 2014; 23: 345&#x2013;349. doi:10.1183/09059180.00007813</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09059180.00007813</ArticleId><ArticleId IdType="pmc">PMC4523084</ArticleId><ArticleId IdType="pubmed">25176970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which results in hospital admission: a systematic review. Int J COPD 2014; 9: 315&#x2013;330. doi:10.2147/COPD.S53255</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S53255</ArticleId><ArticleId IdType="pmc">PMC3974694</ArticleId><ArticleId IdType="pubmed">24729698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollok J, van Agteren JEM, Esterman AJ, et al. . Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2019; 3: CD012347. doi:10.1002/14651858.CD012347.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD012347.pub2</ArticleId><ArticleId IdType="pmc">PMC6400788</ArticleId><ArticleId IdType="pubmed">30838649</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy B, Casey D, Devane D, et al. . Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 2: CD003793. doi:10.1002/14651858.CD003793.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003793.pub3</ArticleId><ArticleId IdType="pmc">PMC10008021</ArticleId><ArticleId IdType="pubmed">25705944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon CS, Waller JW, Cook RM, et al. . Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest 2019; 156: 80&#x2013;91. doi:10.1016/j.chest.2019.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.04.009</ArticleId><ArticleId IdType="pubmed">31034818</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner M, Holzhauer-Barrie J, Lowe D,et al. . 
Pulmonary Rehabilitation: Time to Breathe Better. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Resources and Organisation of Pulmonary Rehabilitation Services in England and Wales 2015. 2015. www.rcplondon.ac.uk/file/2134/download
Date last accessed: 12 August 2023.</Citation></Reference><Reference><Citation>Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis 2011; 8: 89&#x2013;99. doi:10.1177/1479972310393756</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1479972310393756</ArticleId><ArticleId IdType="pubmed">21596892</ArticleId></ArticleIdList></Reference><Reference><Citation>Coventry PA, Bower P, Keyworth C, et al. . The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One 2013; 8: e60532. doi:10.1371/journal.pone.0060532</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060532</ArticleId><ArticleId IdType="pmc">PMC3621386</ArticleId><ArticleId IdType="pubmed">23585837</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohanpal R, Pinnock H, Steed L, et al. . Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial. Trials 2020; 21: 18. doi:10.1186/s13063-019-3800-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-019-3800-y</ArticleId><ArticleId IdType="pmc">PMC6945421</ArticleId><ArticleId IdType="pubmed">31907074</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan C, Smuk M, Sohanpal R, et al. . Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): statistical analysis plan for a randomised controlled trial. Trials 2020; 21: 858. doi:10.1186/s13063-019-3906-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-019-3906-2</ArticleId><ArticleId IdType="pmc">PMC7559776</ArticleId><ArticleId IdType="pubmed">33059755</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for the Diagnosis, Management and Prevention of COPD. 2022. Available from:
http://goldcopd.org/</Citation></Reference><Reference><Citation>Bjelland I, Dahl AA, Haug TT, et al. . The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69&#x2013;77. doi:10.1016/S0022-3999(01)00296-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(01)00296-3</ArticleId><ArticleId IdType="pubmed">11832252</ArticleId></ArticleIdList></Reference><Reference><Citation>Steed L, Heslop-Marshall K, Sohanpal R, et al. . Developing a complex intervention whilst considering implementation: the TANDEM (Tailored intervention for ANxiety and DEpression Management) intervention for patients with chronic obstructive pulmonary disease (COPD). Trials 2021; 22: 252. doi:10.1186/s13063-021-05203-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05203-x</ArticleId><ArticleId IdType="pmc">PMC8025339</ArticleId><ArticleId IdType="pubmed">33823935</ArticleId></ArticleIdList></Reference><Reference><Citation>Apps LD, Mitchell KE, Harrison SL, et al. . The development and pilot testing of the Self-management Programme of Activity, Coping and Education for Chronic Obstructive Pulmonary Disease (SPACE for COPD). Int J COPD 2013; 8: 317&#x2013;327. doi:10.2147/COPD.S40414</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S40414</ArticleId><ArticleId IdType="pmc">PMC3711650</ArticleId><ArticleId IdType="pubmed">23874093</ArticleId></ArticleIdList></Reference><Reference><Citation>Steed L, Wileman V, Sohanpal R, et al. . Enhancing and assessing fidelity in the TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: development of methods and recommendations for research design. BMC Med Res Methodol 2022; 22: 163. doi:10.1186/s12874-022-01642-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01642-5</ArticleId><ArticleId IdType="pmc">PMC9171991</ArticleId><ArticleId IdType="pubmed">35668365</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Steer RA, Brown GK. Beck Depression Inventory: Manual. San Antonio, The Psychological Corporation, 1996.</Citation></Reference><Reference><Citation>Beck AT, Epstein N, Brown G, et al. . An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893&#x2013;897. doi:10.1037/0022-006X.56.6.893</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0022-006X.56.6.893</ArticleId><ArticleId IdType="pubmed">3204199</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PW, Quirk FH, Baveystock CM, et al. . A self-complete measure for chronic airflow limitation: the St George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321&#x2013;1327. doi:10.1164/ajrccm/145.6.1321</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm/145.6.1321</ArticleId><ArticleId IdType="pubmed">1595997</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne RH, Elsworth GR, Whitfield K. The Health Education Impact Questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Educ Couns 2007; 66: 192&#x2013;201. doi:10.1016/j.pec.2006.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2006.12.002</ArticleId><ArticleId IdType="pubmed">17320338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan O, Gershuny J. Speed-up society? Evidence from the UK 2000 and 2015 time use diary surveys. Sociology 2018; 52: 20&#x2013;38. doi:10.1177/0038038517712914</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0038038517712914</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent E, Petrie KJ, Main J, et al. . The brief illness perception questionnaire. J Psychosom Res 2006; 60: 631&#x2013;637. doi:10.1016/j.jpsychores.2005.10.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2005.10.020</ArticleId><ArticleId IdType="pubmed">16731240</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol . About EQ-5D-5L. 2021. https://euroqol.org/eq-5d-instruments/eq-5d-5l-about
Date last accessed: 15 October 2021.</Citation></Reference><Reference><Citation>Gudmundsson G, Gislason T, Janson C, et al. . Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26: 414&#x2013;419. doi:10.1183/09031936.05.00078504</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00078504</ArticleId><ArticleId IdType="pubmed">16135721</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhan MA, Frey M, B&#xfc;chi S, et al. . The minimal important difference of the Hospital Anxiety and Depression Scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 2008; 6: 46. doi:10.1186/1477-7525-6-46</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-6-46</ArticleId><ArticleId IdType="pmc">PMC2459149</ArticleId><ArticleId IdType="pubmed">18597689</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerbeek M, Wong WK. Sample size formulae for trials comparing group and individual treatments in a multilevel model. Stat Med 2008; 27: 2850&#x2013;2864. doi:10.1002/sim.3115</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3115</ArticleId><ArticleId IdType="pubmed">17960589</ArticleId></ArticleIdList></Reference><Reference><Citation>Candlish J, Teare MD, Dimairo M, et al. . Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study. BMC Med Res Methodol 2018; 18: 105. doi:10.1186/s12874-018-0559-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-018-0559-x</ArticleId><ArticleId IdType="pmc">PMC6186141</ArticleId><ArticleId IdType="pubmed">30314463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunik ME, Veazey C, Cully JA, et al. . COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 2008; 38: 385&#x2013;396. doi:10.1017/S0033291707001687</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291707001687</ArticleId><ArticleId IdType="pubmed">17922939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynninen MJ, Bjerke N, Pallesen S, et al. . A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med 2010; 104: 986&#x2013;994. doi:10.1016/j.rmed.2010.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2010.02.020</ArticleId><ArticleId IdType="pubmed">20346640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers F, Jonkers CCM, Bosma H, et al. . Improving quality-of-life in depressed COPD patients: effectiveness of a minimal psychological intervention. J COPD 2010; 7: 315&#x2013;322. doi:10.3109/15412555.2010.510156</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15412555.2010.510156</ArticleId><ArticleId IdType="pubmed">20854045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove DG, Lomborg K, Jensen AK, et al. . Efficacy of a minimal home-based psychoeducative intervention in patients with advanced COPD: a randomised controlled trial. Respir Med 2016; 121: 109&#x2013;116. doi:10.1016/j.rmed.2016.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2016.11.009</ArticleId><ArticleId IdType="pubmed">27888984</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle C, Bhar S, Fearn M, et al. . The impact of telephone-delivered cognitive behaviour therapy and befriending on mood disorders in people with chronic obstructive pulmonary disease: a randomized controlled trial. Br J Health Psychol 2017; 22: 542&#x2013;556. doi:10.1111/bjhp.12245</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjhp.12245</ArticleId><ArticleId IdType="pubmed">28544504</ArticleId></ArticleIdList></Reference><Reference><Citation>Heslop-Marshall K, Carrick-Sen D, Newton J, et al. . Randomised controlled trial of cognitive behavioural therapy in COPD. ERJ Open Res 2018; 4: 00094-2018. doi:10.1183/23120541.00094-2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00094-2018</ArticleId><ArticleId IdType="pmc">PMC6250562</ArticleId><ArticleId IdType="pubmed">30479999</ArticleId></ArticleIdList></Reference><Reference><Citation>Pumar MI, Roll M, Fung P, et al. . Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation. J Thorac Dis 2019; 11: S2238&#x2013;S2253. doi:10.21037/jtd.2019.10.23</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2019.10.23</ArticleId><ArticleId IdType="pmc">PMC6831925</ArticleId><ArticleId IdType="pubmed">31737351</ArticleId></ArticleIdList></Reference><Reference><Citation>Usmani ZA, Carson KV, Heslop K, et al. . Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 3: CD010673. doi:10.1002/14651858.CD010673.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010673.pub2</ArticleId><ArticleId IdType="pmc">PMC6464539</ArticleId><ArticleId IdType="pubmed">28322440</ArticleId></ArticleIdList></Reference><Reference><Citation>Barradell A, Sohanpal R. Patient and public involvement and its vital role in the tandem COPD study: a randomised controlled trial. EMJ Respir 2017; 5: 56&#x2013;58.</Citation></Reference><Reference><Citation>NHS Digital . Psychological Therapies: reports on the use of IAPT services, England. July 2019 Final including reports on the IAPT pilots. 2019. https://digital.nhs.uk/data-and-information/publications/statistical/psychological-therapies-report-on-the-use-of-iapt-services/july-2019-final-including-reports-on-the-iapt-pilots
Date last accessed: 22 December 2022.</Citation></Reference><Reference><Citation>Kelly M, Steed L, Sohanpal R, et al. . The TANDEM trial: protocol for the process evaluation of a randomised trial of a complex intervention for anxiety and/or depression in people living with chronic obstructive pulmonary disease (COPD). Trials 2021; 22: 495. doi:10.1186/s13063-021-05460-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05460-w</ArticleId><ArticleId IdType="pmc">PMC8313120</ArticleId><ArticleId IdType="pubmed">34311766</ArticleId></ArticleIdList></Reference><Reference><Citation>Wileman V, Rowland V, Kelly M, et al. . Implementing psychological interventions delivered by respiratory professionals for people with COPD. A stakeholder interview study. NPJ Prim Care Respir Med 2023; 33: 35. doi:10.1038/s41533-023-00353-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41533-023-00353-8</ArticleId><ArticleId IdType="pmc">PMC10600190</ArticleId><ArticleId IdType="pubmed">37880342</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb SE, Hansen Z, Lall R, et al. . Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis. Lancet 2010; 375: 916&#x2013;923. doi:10.1016/S0140-6736(09)62164-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)62164-4</ArticleId><ArticleId IdType="pubmed">20189241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>